Evidence map›Paper›PMID 35847735›Full record

ArticleEJHaem2020

Relapse of follicular lymphoma arising from a non-t(14;18) clone.

Yasuyuki Otsuka, Momoko Nishikori, Masakazu Fujimoto, Kensuke Nakao, Masakatsu Hishizawa, Hironori Haga, Akifumi Takaori-Kondo

Open access · diamondAbstract readCase Reports
In one paragraph

Article in EJHaem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yasuyuki OtsukaDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Momoko NishikoriDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0003-4171-2162
Masakazu FujimotoDepartment of Diagnostic Pathology Kyoto University Hospital Kyoto Japan.
Kensuke NakaoDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Masakatsu HishizawaDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Hironori HagaDepartment of Diagnostic Pathology Kyoto University Hospital Kyoto Japan.
Akifumi Takaori-KondoDepartment of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Kyoto University · JPKyoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraclonal diversity is commonly observed in patients with follicular lymphoma (FL), whereas tumor cells at the onset and relapse usually share early genetic events such as VDJ rearrangement of the immunoglobulin genes and t(14;18) translocation. We report a case of FL with relapse with FL that was clonally different from the tumor cells at onset. A 59-year-old male presented with paraaortic lymph node swelling and thickening of the right renal pelvic and ureteral wall was histologically diagnosed as FL, grade 1. Karyotypic analysis revealed t(14;18)(q32;q21) with +12 and +der(18)t(14;18). Ten years after the initial diagnosis, he suddenly developed systemic lymphadenopathy as a second relapse, and histological examination led to the diagnosis of FL grade 3B with diffuse large B-cell lymphoma. Surprisingly, karyotypic analysis demonstrated the presence of +12 and 3q27 abnormality, which was proved to be a BCL6 translocation by fluorescence in situ hybridization, but the absence of t(14;18)(q32;q21). We compared VDJ rearrangement of the FL cells at onset and relapse and found that they were completely independent of each other. These tumor cells sharetrisomy 12 as a common genetic abnormality, and it is speculated that trisomy 12 may have occurred earlier than BCL2 and BCL6 translocations. These results suggest that there can even be cases of "relapse" of FL with an independent origin of the primary tumor cells. Our observation highlights the importance of re-biopsy of relapsed FL, especially when it occurs after a long remission with different clinical presentation from that at the onset.

Indexed as

clonalitycytogeneticslymphomas

Identifiers

PMID35847735
PMCPMC9176117
OpenAlexW3033779445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.